arrow
C

C. Mee Ling Munier

University of New South Wales
H指数:27
被引数:3,216

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Human axillary lymph node T follicular helper (Tfh) and Precursor-Tfh cells exhibit functional flexibility following seasonal influenza vaccination

人类腋窝淋巴结T滤泡辅助细胞(Tfh)和前体Tfh细胞在季节性流感疫苗接种后表现出功能可塑性

2025-10-230
OAAI
Expanded CD16+CD56+Granzyme B+ NK like CD8+ T cells an off target effect of bruton’s tyrosine kinase inhibitors in Waldenström macroglobulinemia

扩增的CD16+CD56+Granzyme B+ NK样CD8+ T细胞是Bruton’s tyrosine kinase inhibitors在Waldenström macroglobulinemia中的脱靶效应。

2025-10-050
OA
Zeb2 drives the formation of CD11c+ atypical B cells to sustain germinal centers that control persistent infection

Zeb2驱动CD11c非典型b细胞的形成,以维持控制持续感染的生发中心

2024-03-2914
PRE
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells

响应SARS-CoV-2感染的高滴度中和抗体需要RBD特异性CD4 T细胞,包括增殖记忆细胞

2022-12-0511
OAAI
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

SARS-CoV-2 Omicron BA.5: 进化趋向性和逃避有效的体液反应和抵抗临床免疫治疗相对于病毒变异的关注

2022-10-0162
OAAI
Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses

用BNT162b2免疫治疗的惰性淋巴瘤患者的抗刺中和IgG SARS-CoV-2变体减少,但保留了抗原特异性T细胞反应

2022-06-0912
OAAI
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
2022-05-300
OAAI
Human MAIT cells respond to and suppress HIV-1

人类MAIT细胞响应并抑制HIV-1

2021-12-2423
PRE
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis
2020-08-1918
OAAI